Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
13 studies found for:    Multifocal Motor Neuropathy
Show Display Options
RSS Create an RSS feed from your search for:
Multifocal Motor Neuropathy
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Phase III Clinical Trial of NPB-01maintenance Therapy in Patients With Multifocal Motor Neuropathy.
Condition: Multifocal Motor Neuropathy
Intervention: Drug: NPB-01
2 Completed Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy
Condition: Multifocal Motor Neuropathy
Interventions: Drug: Subcutaneous immunoglobulin;   Drug: Intravenous immunoglobulin
3 Completed
Has Results
Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy
Condition: Multifocal Motor Neuropathy
Interventions: Biological: Immune Globulin Intravenous (human), 10%;   Biological: 0.25% human albumin solution (Placebo)
4 Enrolling by invitation Efficacy and Safety of HyQvia (Immunoglobulin 10% With Recombinant Hyaluronidase) in Multifocal Motor Neuropathy (MMN)
Condition: Multifocal Motor Neuropathy
Interventions: Drug: HyQvia;   Drug: Subcuvia
5 Not yet recruiting HyQvia in Multifocal Motor Neuropathy
Condition: Multifocal Motor Neuropathy
Intervention: Drug: rHuPH20
6 Completed
Has Results
A Study of Purified Human Antibodies Administered Subcutaneously to Patients With Multifocal Motor Neuropathy (MMN)
Condition: Multifocal Motor Neuropathy (MMN)
Intervention: Biological: Vivaglobin
7 Completed Effect of Resistance and Aerobic Exercise in CIDP or MMN
Conditions: Chronic Inflammatory Demyelinating Polyneuropathy;   Multifocal Motor Neuropathy
Interventions: Other: Resistance training;   Other: Aerobic training
8 Completed LIME Study (LFB IVIg MMN Efficacy Study)
Condition: Motor Neuron Disease
Interventions: Drug: Biological : I10E (Human normal Immunoglobulin for intravenous administration 100mg/mL);   Drug: Biological: Kiovig® (Human normal Immunoglobulin for intravenous administration 100mg/mL)
9 Completed Immunoglobulin Dosage and Administration Form in CIDP and MMN
Conditions: Chronic Inflammatory Demyelinating Polyneuropathy;   Multifocal Motor Neuropathy;   Hemolytic Anemia
Intervention: Drug: Immunoglobulins
10 Unknown  Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
Conditions: Guillain-Barre Syndrome;   CIDP;   Multifocal Motor Neuropathy
Intervention:
11 Recruiting sCD163 & CD19 as Candidate Biomarkers in CIDP and MMN
Condition: Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Interventions: Procedure: Lumbar puncture;   Procedure: Blood sample
12 Recruiting A Study to Evaluate the Performance of a Diagnostic Test in ALS
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Procedure: Lumbar puncture
13 Not yet recruiting Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin
Condition: Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Interventions: Procedure: Muscle Magnetic Resonance Imaging (RMI) evaluation;   Device: MRI

Study has passed its completion date and status has not been verified in more than two years.